Group One Trading’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1K Sell
1,300
-1,200
-48% -$10.8K ﹤0.01% 6265
2025
Q4
$22.4K Sell
2,500
-31,500
-93% -$298K ﹤0.01% 6265
2025
Q3
$323K Buy
34,000
+12,300
+57% +$123K 0.01% 4144
2025
Q2
$191K Buy
21,700
+2,200
+11% +$17.9K 0.01% 4388
2025
Q1
$146K Buy
19,500
+18,000
+1,200% +$143K 0.01% 4274
2024
Q4
$12.5K Sell
1,500
-37,300
-96% -$318K ﹤0.01% 5981
2024
Q3
$269K Buy
38,800
+27,800
+253% +$189K 0.01% 3357
2024
Q2
$53.9K Sell
11,000
-1,900
-15% -$9K ﹤0.01% 4475
2024
Q1
$74.8K Sell
12,900
-25,200
-66% -$155K ﹤0.01% 4392
2023
Q4
$250K Buy
38,100
+16,900
+80% +$79K 0.01% 3660
2023
Q3
$102K Sell
21,200
-20,200
-49% -$101K ﹤0.01% 4437
2023
Q2
$211K Buy
41,400
+12,100
+41% +$65.2K 0.01% 3866
2023
Q1
$161K Sell
29,300
-29,500
-50% -$156K 0.01% 3866
2022
Q4
$270K Buy
58,800
+18,900
+47% +$96K 0.01% 3596
2022
Q3
$249K Buy
39,900
+13,400
+51% +$75.9K 0.01% 3931
2022
Q2
$118K Sell
26,500
-185,600
-88% -$846K ﹤0.01% 4825
2022
Q1
$1.07M Sell
212,100
-21,600
-9% -$137K 0.02% 3009
2021
Q4
$2.04M Buy
233,700
+155,400
+198% +$1.39M 0.04% 2577
2021
Q3
$731K Buy
78,300
+33,100
+73% +$334K 0.02% 3766
2021
Q2
$579K Buy
45,200
+18,100
+67% +$195K 0.01% 4062
2021
Q1
$249K Buy
+27,100
New +$237K 0.01% 4790

Other funds holding ZVRA